InvestorsHub Logo
Followers 6
Posts 461
Boards Moderated 0
Alias Born 11/13/2013

Re: None

Wednesday, 04/16/2014 3:26:44 AM

Wednesday, April 16, 2014 3:26:44 AM

Post# of 80490
Future are all green
http://money.cnn.com/data/premarket/
Hopefully we can recover the loss yesterday and back to the low $7s today.

Also found the following highlight posted on OncLive website last Thursday 4/10/14:

"... In the dozen years since, Druker’s life has changed—and stayed the same. Druker still spends a fair amount of time conducting research in his 16-person lab at OHSU, where he remains focused on finding new and better treatments for CML and other leukemias. Of particular interest has been overcoming the resistance to imatinib that arises in about 15% of patients with CML within five years of beginning treatment.

Until recently, while there were already three TKIs on the market for refractory CML, “There was still one mutation that none of those drugs would shut down—T315I,” Druker said. “We worked for close to six years testing drugs that Ariad Pharmaceuticals designed until we identified one that shut this down,” Druker said. “The drug, ponatinib, works incredibly well against that mutation and also across the board in CML....”

Hitting the Target: How Druker’s Persistence Helped Launch a New Mode of Attack
http://www.onclive.com/publications/oncology-live/2014/march-2014/hitting-the-target-how-drukers-persistence-helped-launch-a-new-mode-of-attack/3

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.